Department of Anesthesiology
Author Title Type [ Year(Asc)]
Filters: Keyword is Time Factors  [Clear All Filters]
2003
Ryan TA.  2003.  Kiss-and-run, fuse-pinch-and-linger, fuse-and-collapse: the life and times of a neurosecretory granule.. Proc Natl Acad Sci U S A. 100(5):2171-3.
2001
Barbone A, Holmes JW, Heerdt PM, The' AH, Naka Y, Joshi N, Daines M, Marks AR, Oz MC, Burkhoff D.  2001.  Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling.. Circulation. 104(6):670-5.
Chi P, Greengard P, Ryan TA.  2001.  Synapsin dispersion and reclustering during synaptic activity.. Nat Neurosci. 4(12):1187-93.
2000
Boyd WC, Thomas SJ.  2000.  Pro: Magnesium should be administered to all coronary artery bypass graft surgery patients undergoing cardiopulmonary bypass.. J Cardiothorac Vasc Anesth. 14(3):339-43.
1999
Kopman AF, Klewicka MM, Kopman DJ, Neuman GG.  1999.  Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate, short, and ultrashort duration.. Anesthesiology. 90(2):425-31.
Lien CA, Belmont MR, Roth DLWray, Okamoto M, Abalos A, Savarese JJ.  1999.  Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery.. Anesthesiology. 91(1):119-26.
1998
Herman NL, Sheu KL, Van Decar TK, Rubin JD, Gadalla F, Koff HD, Reynolds JE.  1998.  Determination of the analgesic dose-response relationship for epidural fentanyl and sufentanil with bupivacaine 0.125% in laboring patients.. J Clin Anesth. 10(8):670-7.
1997
Bardoni R, Goldstein PA, Lee CJ, Gu JG, MacDermott AB.  1997.  ATP P2X receptors mediate fast synaptic transmission in the dorsal horn of the rat spinal cord.. J Neurosci. 17(14):5297-304.
1996
Lien CA, Hemmings HC, Belmont MR, Abalos A, Hollmann C, Kelly RE.  1996.  A comparison: the efficacy of sevoflurane-nitrous oxide or propofol-nitrous oxide for the induction and maintenance of general anesthesia.. J Clin Anesth. 8(8):639-43.
1995
Velasco FT, Tarlow LS, Thomas SJ.  1995.  Economic rationale for early extubation.. J Cardiothorac Vasc Anesth. 9(5 Suppl 1):2-9.
Surmeier DJ, Bargas J, Hemmings HC, Nairn AC, Greengard P.  1995.  Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons.. Neuron. 14(2):385-97.
1992
Harada K, Adams V, Okamoto M.  1992.  Effect of chronic pre- and post-natal low-dose ethanol exposure on brain enolase isoenzyme activities.. Brain Res. 580(1-2):334-7.
Heerdt PM.  1992.  Intrapulmonary Doppler for continuous measurement of cardiac output.. J Cardiothorac Vasc Anesth. 6(3):382-3.
1989
Hemmings HC, Girault JA, Williams KR, LoPresti MB, Greengard P.  1989.  ARPP-21, a cyclic AMP-regulated phosphoprotein (Mr = 21,000) enriched in dopamine-innervated brain regions. Amino acid sequence of the site phosphorylated by cyclic AMP in intact cells and kinetic studies of its phosphorylation in vitro.. J Biol Chem. 264(13):7726-33.
Goudsouzian NG, Alifimoff JK, Liu LM, Foster V, McNulty B, Savarese JJ.  1989.  Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane.. Br J Anaesth. 62(3):263-8.
1988
Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RP, Sunder N, Weakly JN, Wastila WB, el-Sayad HA.  1988.  The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.. Anesthesiology. 68(5):723-32.
Basta SJ, Savarese JJ, Ali HH, Embree PB, Schwartz AF, Rudd GD, Wastila WB.  1988.  Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.. Anesthesiology. 69(4):478-86.
Ali HH, Savarese JJ, Embree PB, Basta SJ, Stout RG, Bottros LH, Weakly JN.  1988.  Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium.. Br J Anaesth. 61(5):541-6.
Goldhill DR, Embree PB, Ali HH, Savarese JJ.  1988.  Reversal of pancuronium. Neuromuscular and cardiovascular effects of a mixture of neostigmine and glycopyrronium.. Anaesthesia. 43(6):443-6.
1986
Scott RP, Savarese JJ, Basta SJ, Embree P, Ali HH, Sunder N, Hoaglin DC.  1986.  Clinical pharmacology of atracurium given in high dose.. Br J Anaesth. 58(8):834-8.
1985
Scott RP, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG.  1985.  Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response.. Br J Anaesth. 57(6):550-3.
1983
Savarese JJ, Ali HH, Basta SJ, Sunder N, Moss J, Gionfriddo MA, Lineberry CG, Wastila WB, el-Sayad HA, Montague D et al..  1983.  The clinical pharmacology of BW A444U. A nondepolarizing ester relaxant of intermediate duration.. Anesthesiology. 58(4):333-41.
Ali HH, Savarese JJ, Basta SJ, Sunder N, Gionfriddo M.  1983.  Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.. Br J Anaesth. 55 Suppl 1:107S-111S.
1982
Basta SJ, Ali HH, Savarese JJ, Sunder N, Gionfriddo M, Cloutier G, Lineberry C, Cato AE.  1982.  Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.. Anesth Analg. 61(9):723-9.
1980
Ramsey FM, Lebowitz PW, Savarese JJ, Ali HH.  1980.  Clinical characteristics of long-term succinylcholine neuromuscular blockade during balanced anesthesia.. Anesth Analg. 59(2):110-6.